help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yandle, T. G.
Right arrow Articles by Espiner, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yandle, T. G.
Right arrow Articles by Espiner, E. A.

Journal of Clinical Endocrinology & Metabolism, Vol 76, 832-838, Copyright © 1993 by Endocrine Society

ARTICLES

Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure

TG Yandle, AM Richards, A Gilbert, S Fisher, S Holmes and EA Espiner
Department of Endocrinology, Christchurch Hospital, New Zealand.

A RIA for human brain natriuretic peptide (BNP) was developed. Both BNP and atrial natriuretic peptide (ANP) were extracted from human plasma with Vycor glass powder (71% recovery for BNP). The assay had a minimum detection limit of 0.45 fmol/tube and an IC50 of 9 fmol/tube. The within-assay coefficients of variation were 11.4% at 4 pmol/L and 3.2% at 22 pmol/L, and the between-assay coefficient of variation was 11% at 24 pmol/L. There was no significant loss of immunoreactive (IR)-BNP in plasma samples stored at -80 C for 4 weeks. Low rates of labeled BNP and IR-BNP degradation occurred in EDTA plasma incubated at 37 C. The mean venous plasma IR-BNP (6.3 +/- 0.3 pmol/L) in normal subjects (n = 48) was significantly lower than plasma ANP (8.4 +/- 0.6 pmol/L). In contrast to ANP, IR-BNP did not increase when normotensive or hypertensive subjects changed from erect to supine posture. Markedly elevated levels were found in patients with congestive heart failure (mean IR-BNP, 87 +/- 11 pmol/L; ANP, 87 +/- 12 pmol/L; n = 35), recent myocardial infarction (mean IR-BNP, 60 +/- 9 pmol/L; ANP, 33 +/- 6 pmol/L; n = 7), and chronic renal failure. High pressure liquid chromatography of plasma extracts from heart failure subjects revealed both high (mol wt, 10,000) and low (mol wt, 4,000) mol wt IR-BNP. High mol wt BNP was the major component (mean ratio, 1.9:1) and was linearly correlated with low mol wt BNP (r = 0.99). HPLC of plasma extracts from three normal subjects receiving constant infusions of human BNP (2 pmol/kg.min) showed a single major peak eluting in the position of hBNP- 32, with no evidence of high mol wt material. These results show that whereas marked elevations in BNP occur in circulatory disorders, a major (> 50%) and consistent contribution to immunoreactivity is due to precursor forms. Further, compared to ANP, there is no IR-BNP response to supine posture in normal and hypertensive subjects.


This article has been cited by other articles:


Home page
 Circ Heart FailHome page
S. P. Wright, R. N. Doughty, C. M. Frampton, G. D. Gamble, T. G. Yandle, and A. M. Richards
Plasma Urocortin 1 in Human Heart Failure
Circ Heart Fail, September 1, 2009; 2(5): 465 - 471.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. C. Palmer, T. C.R. Prickett, E. A. Espiner, T. G. Yandle, and A. M. Richards
Regional Release and Clearance of C-Type Natriuretic Peptides in the Human Circulation and Relation to Cardiac Function
Hypertension, September 1, 2009; 54(3): 612 - 618.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. C. Palmer, Z. H. Endre, A. M. Richards, and T. G. Yandle
Characterization of NT-proBNP in Human Urine
Clin. Chem., June 1, 2009; 55(6): 1126 - 1134.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. G. Semenov, A. B. Postnikov, N. N. Tamm, K. R. Seferian, N. S. Karpova, M. N. Bloshchitsyna, E. V. Koshkina, M. I. Krasnoselsky, D. V. Serebryanaya, and A. G. Katrukha
Processing of Pro-Brain Natriuretic Peptide Is Suppressed by O-Glycosylation in the Region Close to the Cleavage Site
Clin. Chem., March 1, 2009; 55(3): 489 - 498.
[Abstract] [Full Text] [PDF]

Home page
 Circ Heart FailHome page
E. E. Niederkofler, U. A. Kiernan, J. O'Rear, S. Menon, S. Saghir, A. A. Protter, R. W. Nelson, and U. Schellenberger
Detection of Endogenous B-Type Natriuretic Peptide at Very Low Concentrations in Patients With Heart Failure
Circ Heart Fail, November 1, 2008; 1(4): 258 - 264.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
R S Gabriel, A J Kerr, V Sharma, I S L Zeng, and R A H Stewart
B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation
Heart, July 1, 2008; 94(7): 897 - 902.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Hammerer-Lercher, B. Halfinger, B. Sarg, J. Mair, B. Puschendorf, A. Griesmacher, N. A. Guzman, and H. H. Lindner
Analysis of Circulating Forms of proBNP and NT-proBNP in Patients with Severe Heart Failure
Clin. Chem., May 1, 2008; 54(5): 858 - 865.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. J. Kerr, O. C. Raffel, G. A. Whalley, I. Zeng, and R. A. Stewart
Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation
Eur. Heart J., February 1, 2008; 29(3): 363 - 370.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
W.H. W. Tang, W. Tong, R. W. Troughton, M. G. Martin, K. Shrestha, A. Borowski, S. Jasper, S. L. Hazen, and A. L. Klein
Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure
J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2364 - 2370.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
N. C Van Pelt, R. A H Stewart, M. E Legget, G. A Whalley, S. P Wong, I. Zeng, M. Oldfield, and A. J Kerr
Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis
Heart, June 1, 2007; 93(6): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. R. Seferian, N. N. Tamm, A. G. Semenov, K. S. Mukharyamova, A. A. Tolstaya, E. V. Koshkina, A. N. Kara, M. I. Krasnoselsky, F. S. Apple, T. V. Esakova, et al.
The Brain Natriuretic Peptide (BNP) Precursor Is the Major Immunoreactive Form of BNP in Patients with Heart Failure
Clin. Chem., May 1, 2007; 53(5): 866 - 873.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
D. M. Heublein, B. K. Huntley, G. Boerrigter, A. Cataliotti, S. M. Sandberg, M. M. Redfield, and J. C. Burnett Jr
Immunoreactivity and Guanosine 3',5'-Cyclic Monophosphate Activating Actions of Various Molecular Forms of Human B-Type Natriuretic Peptide
Hypertension, May 1, 2007; 49(5): 1114 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. S.P. Lam, J. C. Burnett Jr, L. Costello-Boerrigter, R. J. Rodeheffer, and M. M. Redfield
Alternate Circulating Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide Forms in the General Population
J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1193 - 1202.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. Liang, J. O'Rear, U. Schellenberger, L. Tai, M. Lasecki, G. F. Schreiner, F. S. Apple, A. S. Maisel, N. S. Pollitt, and A. A. Protter
Evidence for Functional Heterogeneity of Circulating B-Type Natriuretic Peptide
J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1071 - 1078.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. Y.-M. Wang, C. W.-K. Lam, C.-M. Yu, M. Wang, I. H.-S. Chan, Y. Zhang, S.-F. Lui, and J. E. Sanderson
N-Terminal Pro-Brain Natriuretic Peptide: An Independent Risk Predictor of Cardiovascular Congestion, Mortality, and Adverse Cardiovascular Outcomes in Chronic Peritoneal Dialysis Patients
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 321 - 330.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C H Strey, J M Young, J H Lainchbury, C M Frampton, M G Nicholls, A M Richards, and R S Scott
Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure
Heart, November 1, 2006; 92(11): 1603 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. E. Davis, A. M. Richards, M. G. Nicholls, T. G. Yandle, C. M. Frampton, and R. W. Troughton
Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart Failure
Circulation, February 21, 2006; 113(7): 977 - 985.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
L. R. Potter, S. Abbey-Hosch, and D. M. Dickey
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
Endocr. Rev., February 1, 2006; 27(1): 47 - 72.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. Richards, M. G. Nicholls, E. A. Espiner, J. G. Lainchbury, R. W. Troughton, J. Elliott, C. M. Frampton, I. G. Crozier, T. G. Yandle, R. Doughty, et al.
Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 52 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. M. Hawkridge, D. M. Heublein, H. R. Bergen III, A. Cataliotti, J. C. Burnett Jr., and D. C. Muddiman
Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure
PNAS, November 29, 2005; 102(48): 17442 - 17447.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. J. Rodeheffer
Measuring plasma B-type natriuretic peptide in heart failure: Good to go in 2004?
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 740 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Magnusson, O. Melander, B. Israelsson, A. Grubb, L. Groop, and S. Jovinge
Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease
Diabetes Care, August 1, 2004; 27(8): 1929 - 1935.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Davis, C. J. Pemberton, T. G. Yandle, J. G. Lainchbury, M. T. Rademaker, M. G. Nicholls, C. M. Frampton, and A. M. Richards
Urocortin-1 Infusion in Normal Humans
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1402 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. W. Troughton, D. L. Prior, J. J. Pereira, M. Martin, A. Fogarty, A. Morehead, T. G. Yandle, A. M. Richards, R. C. Starling, J. B. Young, et al.
Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 416 - 422.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. P. Wright, T. C.R. Prickett, R. N. Doughty, C. Frampton, G. D. Gamble, T. G. Yandle, N. Sharpe, and M. Richards
Amino-Terminal Pro-C-Type Natriuretic Peptide in Heart Failure
Hypertension, January 1, 2004; 43(1): 94 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. G. Lainchbury, E. Campbell, C. M. Frampton, T. G. Yandle, M. G. Nicholls, and A. M. Richards
Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath
J. Am. Coll. Cardiol., August 20, 2003; 42(4): 728 - 735.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
I Raymond, B A Groenning, P R Hildebrandt, J C Nilsson, M Baumann, J Trawinski, and F Pedersen
The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population
Heart, July 1, 2003; 89(7): 745 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. W. Troughton, C. M. Frampton, T. G. Yandle, E. A. Espiner, G. Nicholls, and M. Richards
Plasma Amino-Terminal B-Type Natriuretic Peptide Measured by Elecsys 2010 Assay in a Trial of Hormone-guided Treatment for Heart Failure
Clin. Chem., July 1, 2003; 49(7): 1212 - 1215.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. M. Sutton, R. A. H. Stewart, I. L. Gerber, T. M. West, A. M. Richards, T. G. Yandle, and A. J. Kerr
Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2280 - 2287.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. M. Richards, M. G. Nicholls, E. A. Espiner, J. G. Lainchbury, R. W. Troughton, J. Elliott, C. Frampton, J. Turner, I. G. Crozier, and T. G. Yandle
B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction
Circulation, June 10, 2003; 107(22): 2786 - 2792.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
H. Ruskoaho
Cardiac Hormones as Diagnostic Tools in Heart Failure
Endocr. Rev., June 1, 2003; 24(3): 341 - 356.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
I. L. Gerber, R. A.H. Stewart, M. E. Legget, T. M. West, R. L. French, T. M. Sutton, T. G. Yandle, J. K. French, A. M. Richards, and H. D. White
Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis
Circulation, April 15, 2003; 107(14): 1884 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
Pacific Study Group and B. Neal
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 270 - 276.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
J. Mair
Role of Cardiac Natriuretic Peptide Testing in Heart Failure
Clin. Chem., July 1, 2002; 48(7): 977 - 978.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. R. McClean, H. Ikram, S. Mehta, J. T. Heywood, M. F. Rousseau, A. L. Niederman, R. F. Sequeira, E. Fleck, S. N. Singh, B. Coutu, et al.
Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects
J. Am. Coll. Cardiol., June 19, 2002; 39(12): 2034 - 2041.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. M. Richards, M. G. Nicholls, R. W. Troughton, J. G. Lainchbury, J. Elliott, C. Frampton, E. A. Espiner, I. G. Crozier, T. G. Yandle, and J. Turner
Antecedent hypertension and heart failure after myocardial infarction
J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1182 - 1188.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
G. A Sagnella
Practical implications of current natriuretic peptide research
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 304 - 315.
[PDF]

Home page
 HeartHome page
S Talwar, I B Squire, P F Downie, J E Davies, L L Ng;, and G F BAXTER
Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina
Heart, October 1, 2000; 84(4): 421 - 424.
[Abstract] [Full Text]

Home page
 J Am Coll CardiolHome page
D. R. McClean, H. Ikram, A. H. Garlick, A. M. Richards, M. G. Nicholls, and I. G. Crozier
The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure
J. Am. Coll. Cardiol., August 1, 2000; 36(2): 479 - 486.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. G. Lainchbury, R. W. Troughton, L. K. Lewis, T. G. Yandle, A. M. Richards, and M. G. Nicholls
Hemodynamic, Hormonal, and Renal Effects of Short-Term Adrenomedullin Infusion in Healthy Volunteers
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1016 - 1020.
[Abstract] [Full Text]

Home page
 HeartHome page
S Talwar, A Siebenhofer, B Williams, and L Ng
Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP
Heart, March 1, 2000; 83(3): 278 - 282.
[Abstract] [Full Text]

Home page
 HeartHome page
K KHAN
Is BNP ready for use in clinical practice?
Heart, August 1, 1999; 82(2): 254 - 255.
[Full Text] [PDF]

Home page
 HypertensionHome page
J. G. Lainchbury, M. G. Nicholls, E. A. Espiner, T. G. Yandle, L. K. Lewis, and A. M. Richards
Bioactivity and Interactions of Adrenomedullin and Brain Natriuretic Peptide in Patients With Heart Failure
Hypertension, July 1, 1999; 34(1): 70 - 75.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. M. Richards, R. Doughty, M. G. Nicholls, S. Macmahon, H. Ikram, N. Sharpe, E. A. Espiner, C. Frampton, and T. G. Yandle
Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction
Circulation, February 16, 1999; 99(6): 786 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. G. Lainchbury, A. M. Richards, M. G. Nicholls, E. A. Espiner, and T. G. Yandle
Brain Natriuretic Peptide and Neutral Endopeptidase Inhibition in Left Ventricular Impairment
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 723 - 729.
[Abstract] [Full Text]

Home page
 HeartHome page
A M Richards, M G Nicholls, T G Yandle, H Ikram, E A Espiner, J G Turner, R C Buttimore, J G Lainchbury, J M Elliott, C Frampton, et al.
Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
Heart, February 1, 1999; 81(2): 114 - 120.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. J. Pemberton, T. G. Yandle, M. T. Rademaker, C. J. Charles, G. D. Aitken, and E. A. Espiner
Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload
Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1200 - H1208.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. M. Richards, M. G. Nicholls, T. G. Yandle, C. Frampton, E. A. Espiner, J. G. Turner, R. C. Buttimore, J. G. Lainchbury, J. M. Elliott, H. Ikram, et al.
Plasma N-Terminal Pro–Brain Natriuretic Peptide and Adrenomedullin : New Neurohormonal Predictors of Left Ventricular Function and Prognosis After Myocardial Infarction
Circulation, May 19, 1998; 97(19): 1921 - 1929.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Daggubati, J. R Parks, R. M Overton, G. Cintron, D. D Schocken, and D. L Vesely
Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
Cardiovasc Res, November 1, 1997; 36(2): 246 - 255.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. G. Lainchbury, A. M. Richards, M. G. Nicholls, P. J. Hunt, H. Ikram, E. A. Espiner, T. G. Yandle, and E. Begg
The Effects of Pathophysiological Increments in Brain Natriuretic Peptide in Left Ventricular Systolic Dysfunction
Hypertension, September 1, 1997; 30(3): 398 - 404.
[Abstract] [Full Text]

Home page
 CirculationHome page
T. Omland, A. Aakvaag, V. V. S. Bonarjee, K. Caidahl, R. T. Lie, D. W. T. Nilsen, J. A. Sundsfjord, and K. Dickstein
Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction : Comparison With Plasma Atrial Natriuretic Peptide and N-Terminal Proatrial Natriuretic Peptide
Circulation, June 1, 1996; 93(11): 1963 - 1969.
[Abstract] [Full Text]

Home page
 HypertensionHome page
G. B. Pidgeon, A. M. Richards, M. G. Nicholls, E. A. Espiner, T. G. Yandle, and C. Frampton
Differing Metabolism and Bioactivity of Atrial and Brain Natriuretic Peptides in Essential Hypertension
Hypertension, April 1, 1996; 27(4): 906 - 913.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society